GRA Eminent Scholar named to lead Georgia’s Solve Sickle Cell Initiative Atlanta, GA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- An accomplished researcher in genetics and sickle cell disease is returning to Georgia to lead a science and medical collaborative that aims to find...

Fulcrum Therapeutics, Inc. (FULC) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fulcrum Therapeutics, Inc. SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....